| __timestamp | ADMA Biologics, Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 2026300000 |
| Thursday, January 1, 2015 | 6745968 | 2682700000 |
| Friday, January 1, 2016 | 8494742 | 2810000000 |
| Sunday, January 1, 2017 | 18092835 | 2582000000 |
| Monday, January 1, 2018 | 22502922 | 2473000000 |
| Tuesday, January 1, 2019 | 25910757 | 2554000000 |
| Wednesday, January 1, 2020 | 35050817 | 2367000000 |
| Friday, January 1, 2021 | 42896889 | 2624000000 |
| Saturday, January 1, 2022 | 52458024 | 2625000000 |
| Sunday, January 1, 2023 | 59020000 | 2917000000 |
In pursuit of knowledge
In the ever-evolving landscape of the biopharmaceutical industry, understanding the financial strategies of key players is crucial. ADMA Biologics, Inc. and Bausch Health Companies Inc. offer a fascinating study in contrasts when it comes to Selling, General, and Administrative (SG&A) expenses. Over the past decade, ADMA Biologics has seen a staggering increase in SG&A spending, growing by over 1,100% from 2014 to 2023. This reflects their aggressive expansion and investment in operational capabilities. In contrast, Bausch Health Companies Inc. has maintained a more stable SG&A expenditure, with a modest 44% increase over the same period. This stability suggests a focus on efficiency and cost management. As we delve into these financial narratives, it becomes clear that each company's approach to SG&A spending is a reflection of its broader strategic priorities.
SG&A Efficiency Analysis: Comparing Novartis AG and ADMA Biologics, Inc.
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
Walgreens Boots Alliance, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Exelixis, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Revenue Insights: ADMA Biologics, Inc. and Bausch Health Companies Inc. Performance Compared
ADMA Biologics, Inc. vs Protagonist Therapeutics, Inc.: SG&A Expense Trends
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
CRISPR Therapeutics AG and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Bausch Health Companies Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Bausch Health Companies Inc. and Xencor, Inc.
Bausch Health Companies Inc. or Evotec SE: Who Manages SG&A Costs Better?